NATtrol Respiratory Syncytial Virus Type A Stock is formulated with purified, intact viral particles that have been chemically modified to render them non-infectious and refrigerator stable. Each vial contains 1.0 mL of NATtrol Respiratory Syncytial Virus Type A stock in a proprietary matrix at the target concentration.

NATtrol Respiratory Syncytial Virus Type A stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of Respiratory Syncytial Virus A nucleic acid. NATtrol Respiratory Syncytial Virus A stock enables laboratories to monitor test variation, lot-to-lot test kit performance, operator variation, and can provide assistance in identifying random or systemic error.

+2? to +8? C.
Product Insert.pdf

Material Safety Data Sheet.pdf